MedTrace Logo

A Study to Evaluate the Clinical Performance of VeriSee GLC for Screening of Glaucoma Suspect Using Color Fundus Images

NCT07550712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 773

Last updated 2026-04-24

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the clinical performance of VeriSee GLC for identifying glaucoma suspects using color fundus images in adult participants. The main questions it aims to answer are:

* What are the sensitivity and specificity of VeriSee GLC for detecting glaucoma suspects based on fundus images?
* How does the performance of VeriSee GLC compare with the reference standard defined by the majority consensus of three independent evaluators?

Researchers will compare the screening results generated by VeriSee GLC with the reference standard to assess its diagnostic performance.

This retrospective study will use previously collected fundus images. VeriSee GLC performs automated image analysis to identify glaucomatous signs, including retinal nerve fiber layer (RNFL) defects, vertical cup-to-disc ratio (VCDR) enlargement, and rim-to-disc ratio (RDR) changes. The output is intended to assist healthcare professionals in identifying glaucoma suspects for referral, rather than providing a definitive diagnosis.

Conditions

Sponsors & Collaborators

  • Acer Medical Inc.

    lead INDUSTRY

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-26
Primary Completion
2024-08-26
Completion
2024-12-27

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07550712 on ClinicalTrials.gov